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Abstract 
A developing field in bioinformatics and medical science is radiomics, the study of data 
generated by radiological imaging. The field is novel, and scientists have begun to pioneer studies 
that will further the scope of preventive medicine. Different imaging modalities have been used in 
radiomics studies, with ultrasound appearing to be the most promising. Vast amounts of data are 
being generated each day with different methodologies and statistical tools consistently 
progressing the scope of analysis and image interpretation. This review focuses on radiomics 
applied to ultrasound data, analysis tools, and breast cancer – a disease where radiomics research 
looks most promising. 
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Introduction 
         The data-driven 21st century has prompted interdisciplinary research, interfacing the 
clinical and computer sciences. A byproduct of the Big Data Revolution is radiomics (also 
known as radiogenomics, or computer-aided diagnostics) which uses radiological images and 
scans, converts them to higher dimensional data, and extracts information to make diagnostic 
conclusions (1,2). 
          
         High throughput computing allows a tremendous amount of information to be extracted 
from CT, PET and MRI data, reflecting underlying pathophysiology of the patient (3). Benefiting 
greatly from these operations is precision medicine, which focuses on developing and 
administering timely patient-specific treatments (3). While radiomics technologies would not be 
used as stand-alone diagnostic tools, they would provide extraordinary decision support, helping 
diagnose and treat conditions early. 
  
         Radiomics is implemented in many different radiological modalities, but ultrasound (also 
known as sonoelastography, tomosynthesis, or ultrasound elastography) has been overlooked. In 
a 2014 study by Parker et al., it was found that ultrasound scans could be used in conjunction 
with CT without compromising patient outcomes (4). In that particular study, patients saved 
more than 450 dollars per individual scan, and also prevented potential excess exposure to 
radiation (4). Since then, new ultrasound transducers have been developed, with some, such as 
the Clarius, handheld and controlled by a mobile app. 
  
This review aims to discuss how radiomics has been implemented to ultrasound images, 
in the breast, analyze the prospective directions of the technology, and predict the future of 
patient outcomes. 
  
Materials and Methods 
  
Early Radiomics Research 
As early as 2000, mammographic parenchymal patterns were analyzed using computer 
programs (5). However, only in the last few years has it been possible to improve the accuracy 
and precision of these systems (2). Using tomosynthesis and recent advances in medical imaging 
resolution, it is possible to pinpoint with over 90 percent accuracy the presence of cancerous 
tissues in the breast without exposing women to excess radiation via repeated mammograms (2). 
  
“New-Age” Radiomics Studies 
         Recent radiomics studies affirm that the discipline will soon be a fixture in medical 
diagnoses. A 2017 paper by Guo et al. extracted information from sonoelastography data and 
differentiated between malignant and benign breast ductal carcinomas with statistically 
significant accuracy (6). The group partitioned and assessed tumor boundaries, and in cases 
where the program could not perform automatically, seasoned radiologists were called to 
manually refine the boundary regions (6). With machine-learning and artificial intelligence 
driving the study, it is possible to envision a future where sonoelastography systems have 
autonomy in reading medical scans. 
  
The shapes, margins, boundaries, and patterns were collected from 215 patients of Asian 
heritage over a period of two years (6). However, with human populations, it is important to 
consider the variability between people of different evolutionary origins (7). Several of the most 
recent radiomics studies are conducted by groups in China (6,8,9,10). Despite their overall 
success, the systems cannot be translated to populations of European or African ancestry without 
accounting for differences in histology (2). 
  
But Why Breast Cancer? 
Imaging the breast is often ideal for radiological data collection and has been the basis for 
early radiomic experimentation. Breast tissue is ideal for post-hoc studies, because patients often 
self-diagnose the presence of tumors via palpation. This makes them likely to seek help early, 
crafting a robust dataset of early images. As a result, computer-aided diagnostics are afforded 
training datasets that are unique to breast cancers and can be used to diagnose the beginning 
stages of the disease (9). Preventative imaging in combination with histological data, may even 
allow women to identify breast cancer well before identifying tumors independently (6). 
  
 
East vs. West and its Effect on a Dataset 
Radiomics studies in Western countries are markedly lagging. This may be due to 
stringent medical protocols surrounding mammograms, particularly in the United States (2). 
When breast density is high, the sensitivity of mammograms reduces, leaving cancer undetected, 
and often putting these women at high risk (2). Medical protocol often keeps the records of these 
women sealed, and clinical research becomes nearly impossible with regulations surrounding 
medical informatics due to HIPAA (11). While ethical research standards must not be 
compromised, patients should be made aware of the overall benefits of providing anonymous 
data points for training models to detect breast cancer early. 
  
The increased power of these tests lies in the recent ability of computers to handle large 
datasets. Studies, such as the one conducted by Zhang et al., truly capitalize on the allowances of 
Big Data – having a high throughput dataset consisting of over 364 features analyzed over 117 
patients who had 45 malignant and 75 benign breast tumors (10). Other studies, especially in 
countries like Italy and the United States, do not analyze nearly as many features or patients, 
with Tagliafico et al. only analyzing tomosynthesis images from 45 women (2). Interestingly, 
Guo et al., another Chinese research group, conducted a post-hoc analysis on ultrasound imaging 
from N=215 women (6).  
Discussion 
         Using ultrasound modalities to diagnose cancer proves beneficial to both patients and 
physicians alike. Low doses of radiation, reduced imaging costs, and out-patient evaluation make 
it one of the most promising radiological modalities (4). Additionally, the big-data revolution 
makes it incredibly easy to evaluate images and obtain thorough information from available 
datasets (3). 
  
         Radiomics has just begun to take a stronghold in next-generation medical care. Although 
many groups are consistently creating evaluation models that accurately diagnose cancers more 
than 90 percent of the time, it is important to recognize that these results are not translatable 
across human populations, or cancers (2). Likely, other research groups will be creating decision 
support models for a range of diseases, not just cancer, across different populations, age groups, 
and genders, among other factors. 
  
         As the sciences become more interdisciplinary, it is critical that physicians and scientists 
work together to create medical diagnostics that employ the newest innovations of their 
respective fields. Although cancer remains a scary word, the allowances of the 21st century 
provide hope that with good tools, models, and diagnostic criteria it can be diagnosed early – 
perhaps just by looking at a picture. 
